Sentences with phrase «pharmaceutical industry stocks»

Because of the unique requirements for bringing products to market, pharmaceutical industry stocks are best analyzed by using certain key financial ratios.

Not exact matches

Pharma and biotech stocks swooned recently (the S&P Pharmaceuticals Select Industry Index is down 25 % in the last three months), largely on concerns about greater drug price regulation.

He has also served as Delaware counsel for directors and board committees for such corporations as ABB, Ltd., Adelphia Communications Corporation, Airgas, Inc., Affiliated Computer Services, Inc., Alpha Natural Resources, Inc., AMF Holdings, Inc., Anheuser Busch Companies, Inc., Applied Materials, Inc., Ashworth, Inc., Bank of America Corporation, BarnesandNoble.com, Biosite, Inc., Cablevision Systems Corporation, Caterpillar, Inc., Citigroup, Inc., Clear Channel Outdoor Holdings, Inc., Coeur Mining, Inc., Computer Associates International, Inc., Cornerstone Therapeutics, Inc., Countrywide Financial Corporation, Countrywide Home Loans, Inc., Cysive, Inc., Danfoss A / S, Dreamworks Animation SKG, Duncan Energy Partners, E. I. du Pont de Nemours & Co., Inc., EON Labs, Inc., Epicor Software Corporation, Erickson Air Crane Inc., Fairfield Communities, Inc., FEDEX Corporation, First Franklin Financial Corporation, Fox & Hound Restaurant Group, FTI Consulting Inc., G.P. Strategies Inc., Gemstar International Group Ltd., Genencor International, Inc., Golden Telecom, Inc., Goldman Sachs, Google Inc., Health Management Associates, Inc., Hewlett - Packard Company, Hilton Worldwide Holdings, Inc., Houlihan's Restaurants, Inc., Huntsman Corporation, IGEN, Inc., ImClone Systems Incorporated, infoUSA, Inc., Insituform East, Inc., Intel Corporation, IntercontinentalExchange, Inc., iPass, Inc., Kenetech Corporation, Levi Strauss Associates, Inc., Liberty Media Corporation, Lifepoint Hospitals, Inc., Lorillard, Inc., Maytag Corporation, Micro General Corporation, Motorola, Inc., National Amusements, Inc. (majority stockholder of Viacom), National Steel Corporation, Net2Phone, News Corporation, NRG Energy, Inc., OEC Corporation, Online - City Search, Inc., PeopleSoft, Inc., Pharmacia Corporation, Phonefree.com, PLM International Inc., Printcafe Software, Inc., Pure Resources, Inc., Quest Software, Rent - A-Center, Inc., Rental Service Corporation, Republic Industries, Inc., Rockefeller Center Properties, Inc., Siliconix Incorporated, Simon Property Group Inc., Softbank Corp., Sotheby's, Space Imaging, Inc., Stock Building Supply Holdings, Inc., Suntory Holdings Limited, Take Two Interactive Software, Inc., Teppco Partners, L.P., The Hertz Corporation, The Talbots, Inc., Teva Pharmaceuticals USA, Inc., The Vanguard Group, Inc., The Walt Disney Company, TicketMaster, Todd A-O Corporation, Triad Hospitals, Inc., Unico Corporation, UTStarcom, Inc., Utz Quality Foods, Inc., Venoco, Inc., Veterinary Centers of America, Inc., VMWare, Inc., Walmart Stores, Inc., Walter Industries, Inc., Wheeling - Pittsburgh Corporation, Whistlepig, LLC, Wynn Resorts, Ltd., Zynga, Inc..

Sally Evans, a 61 - year - old pharmaceutical - industry sales analyst in the Chicago area, recalls her friends «bailing from the market,» even as she increased her retirement - account contributions and invested more aggressively in stocks.

With almost 200 stocks in its portfolio, the iShares ETF claims about 80 % of its assets are invested in biotechnology specifically, with the remaining 20 % split between pharmaceutical companies and businesses specializing in tools and services for the life sciences industry.

These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.

I thought about investing in stocks in the pharmaceutical industry, because people might get ill and stressed out more often.

Consolidation and high volume are necessary to generate sufficient profits to justify higher stock valuations given the extremely competitive and sometimes deflationary environment in the pharmaceutical retailers industry.

These are the funds / schemes which invest in the securities of only those sectors or industries as specified in the offer documents, e.g., Pharmaceuticals, Software, Fast Moving Consumer Goods (FMCG), Petroleum stocks, Information Technology (IT), Banks, etc..

While the SEC and the IRS are not completely clear on what a «substantially similar stock» means exactly, to be on the safe side, it is important that if stock A was a stock in the pharmaceutical industry, you don't purchase an identical stock from an identical pharmaceutical company (stock B) within that 30 - day window.

The classic defensive stock is in the pharmaceutical, utility or consumer staple industry.

Deeply committed in being a part of the pharmaceutical industry, I aspire to find a position as a pharmacist wherein my skills at dealing with customers, reading prescriptions, dispensing medications, managing stocks and handling cash books can be fully utilized.

While Clinton, while campaigning, made known her desire to take on the pharmaceutical industry, the energy sector and financial services, stock in some of those categories may enjoy a bounce now that their legal paths forward are clearer.